EMERGEX VACCINES LTD Alternatives & Competitors

12 companies similar to EMERGEX VACCINES LTD — A UK biotechnology company developing T cell-priming immune set-point candidates...

FLUGEN, INC.

Transforming vaccine efficacy in respiratory disease.

6 Grant $71.35M

Biotechnology Health Care +1

X-Vax Technology

Pioneering the future of vaccines to conquer mucosal infections and protect millions globa...

Series A $56.00M

Biotechnology Health Care

Curevo Vaccine

A clinical-stage biotech company developing amezosvatein, a vaccine for shingles and chick...

44 Acquired $196.00M

Bothell, United States

Biopharma Biotechnology +2

BioVaxys Technology Corp.

Antiviral and Anticancer Vaccine Platforms Harnessing the Power of T-Cells

5 Post-IPO Equity

Etobicoke, Canada

Biopharma Biotechnology

Track all EMERGEX VACCINES LTD competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Emmes

The Industry’s First Native Digital and AI Specialty CRO

1294 Private Equity

Rockville, United States

Biopharma Biotechnology +1

Valneva

Specialty vaccine company focused on prevention of infectious diseases with major unmet ne...

637 Grant $720.10M

Saint-herblain, France

Biotechnology Health Care +1

Novavax

Powering innovation. Protecting health.

970 Post-IPO Equity $2.71B

Gaithersburg, United Stat...

Biotechnology Health Care +1

ILiAD Biotechnologies

ILiAD is advancing the next generation pertussis vaccine for the prevention of whooping co...

29 Series B $216.47M

Weston, United States

Biotechnology Health Care +1

Memgen, Inc.

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

7 Venture round

Houston, United States

Biotechnology Health Care +2

Osivax

Pioneering A New Class of Universal Vaccines

53 Grant $53.30M

Lyon, France

Biotechnology Health Care

ACM Biolabs

19 Venture round $6.80M

Singapore, Singapore

Biotechnology Health Care

Affinivax Inc.

23 Grant $377.49M

Cambridge, United States

Biotechnology Health Care +1

About EMERGEX VACCINES LTD

Emergex Vaccines is a pioneering UK biotechnology company that focuses on developing T cell-priming immune set-point candidates to combat infectious diseases. Founded in 2016, the company has its headquarters in the United Kingdom and an operating subsidiary in Pennsylvania, USA. Emergex's innovative approach involves...

Taxonomy

T Cell-Priming Vaccines, Infectious Diseases, Clinical-Stage Biotechnology, Immunotherapy, Vaccine Development, Pandemic Prevention, Pathogen-Targeted Immunotherapy, Nanotechnology In Vaccines, Global Health, Immunoproteomics, Clinical Trials, Public Health, Disease Prevention, Low-Resource Environments

Frequently Asked Questions

Companies similar to EMERGEX VACCINES LTD include FLUGEN, INC., X-Vax Technology, Curevo Vaccine, BioVaxys Technology Corp., Emmes. They work in Biotechnology and Health Care and share EMERGEX VACCINES LTD's focus on infectious diseases, vaccine development and clinical trials.

Bounce Watch lists 12 companies that share EMERGEX VACCINES LTD's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches EMERGEX VACCINES LTD and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

EMERGEX VACCINES LTD Profile FLUGEN, INC. Alternatives X-Vax Technology Alternatives Curevo Vaccine Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at EMERGEX VACCINES LTD on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.